Nautilus Biotechnology, Inc. (NAUT) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $12.39M | -55.2% |
| 2024 | $27.65M | +42.5% |
| 2023 | $19.40M | -83.1% |
| 2022 | $114.52M | -38.3% |
| 2021 | $185.62M | +407.1% |
| 2020 | $36.61M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $12.39M | -55.2% |
| 2024 | $27.65M | +42.5% |
| 2023 | $19.40M | -83.1% |
| 2022 | $114.52M | -38.3% |
| 2021 | $185.62M | +407.1% |
| 2020 | $36.61M | — |